TGD001 Treatment in Thrombotic Microangiopathies

Clinical trial NCT07459114 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07459114
Sponsor: TargED Biopharmaceuticals B.V.
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Thrombotic Microangiopathies ITP Immune-Mediated Thrombocytopenia

Start date: 2026-05-31
Primary completion: 2028-05-31
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.